Peripheral neuropathy is characterized by nerve damage, particularly in the lower limbs, and can cause symptoms like pain, numbness, and reduced nerve conduction velocity, significantly impacting the patient’s quality of life.
In a quest to find effective treatments for this condition, a recent study published by the Turkish Society of Physical Medicine and Rehabilitation revealed astonishing success using a specific electromagnetic therapy.
This method is actually very simple, and you can have it done anywhere in the world. Best of all it’s 100% safe and causes no side effects.
The study, conducted between January and October 2019, involved 24 type 2 diabetic patients (eight males and 16 females) with an average age of 60.4 years.
These participants were divided into two groups: a control group and a study group, each consisting of 12 individuals.
It aimed to evaluate the effects of Tecar therapy, a non-invasive treatment that uses high-frequency electric currents to stimulate tissue repair and relieve pain. Tecar therapy is shown to have an effect on neuropathy symptoms and tibial nerve conduction velocity—a measure of how fast electrical signals travel through the tibial nerve.
Accordingly, participants in the study group received Tecar therapy with an intensity between 10 and 30% over the course of 10 sessions. The control group underwent the same protocol, but with zero intensity, effectively making it a sham treatment.
The researchers assessed the neuropathy symptoms and nerve conduction velocity of the participants at three different stages: at the beginning of the study, after completing 10 sessions, and six weeks post-treatment.
The results were revealing.
Initially, there were no significant differences between the groups, indicating that the participants were comparable at the study’s start.
However, as the treatments progressed, the improvements in neuropathy symptoms in the study group were significantly greater than those in the control group at all stages of the evaluation.
-
1. After the completion of 10 sessions, both groups showed significant improvement in neuropathy symptoms and tibial nerve conduction velocity. However, the improvements were more substantial in the study group.
2. Six weeks after the end of the sessions, the study group still showed significant improvements in their symptoms and nerve conduction velocity. In contrast, the control group did not exhibit any long-term changes in these outcomes.
This shows that Tecar therapy could be a viable option for managing neuropathy symptoms as well as restoring some nerve functions affected by diabetes.
Tecar therapy is the painless use of high-frequency electric currents to transfer energy to body tissue. It is already widely used for muscle and joint pain relief and to accelerate healing from sports injuries.